At a pre-planned analysis, zilovertamab vedotin in combination with R-CHP achieved a 100% (n=15 ... which are often categorized into two main types – Hodgkin lymphoma and non-Hodgkin lymphoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback